Global Companion Diagnostics Market Research Report 2024(Status and Outlook)
Report Overview:
The Global Companion Diagnostics Market Size was estimated at USD 4575.83 million in 2023 and is projected to reach USD 9628.28 million by 2029, exhibiting a CAGR of 13.20% during the forecast period.
This report provides a deep insight into the global Companion Diagnostics market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Companion Diagnostics Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Companion Diagnostics market in any manner.
Global Companion Diagnostics Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Roche Holdings
Abbott Laboratories
Thermo Fisher Scientific
Agilent Technologies
Life Technologies
GE Healthcare
Agendia
Qiagen
Genomic Health
Myriad Genetics
Advanced Cell Diagnostics
Danaher
Applied Proteomics
Market Segmentation (by Type)
Polymerase Chain Reaction (PCR)
Immunohistochemistry (IHC)
In Situ Hybridization (ISH)
Next Generation Sequencing (NGS)
Market Segmentation (by Application)
Hospitals
Pharmaceutical Companies
Laboratories
Other
Geographic Segmentation
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Note: this report may need to undergo a final check or review and this could take about 48 hours.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Companion Diagnostics Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
The Global Companion Diagnostics Market Size was estimated at USD 4575.83 million in 2023 and is projected to reach USD 9628.28 million by 2029, exhibiting a CAGR of 13.20% during the forecast period.
This report provides a deep insight into the global Companion Diagnostics market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Companion Diagnostics Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Companion Diagnostics market in any manner.
Global Companion Diagnostics Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Roche Holdings
Abbott Laboratories
Thermo Fisher Scientific
Agilent Technologies
Life Technologies
GE Healthcare
Agendia
Qiagen
Genomic Health
Myriad Genetics
Advanced Cell Diagnostics
Danaher
Applied Proteomics
Market Segmentation (by Type)
Polymerase Chain Reaction (PCR)
Immunohistochemistry (IHC)
In Situ Hybridization (ISH)
Next Generation Sequencing (NGS)
Market Segmentation (by Application)
Hospitals
Pharmaceutical Companies
Laboratories
Other
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Companion Diagnostics Market
- Overview of the regional outlook of the Companion Diagnostics Market:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value (USD Billion) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Note: this report may need to undergo a final check or review and this could take about 48 hours.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Companion Diagnostics Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Companion Diagnostics
1.2 Key Market Segments
1.2.1 Companion Diagnostics Segment by Type
1.2.2 Companion Diagnostics Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 COMPANION DIAGNOSTICS MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Companion Diagnostics Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Companion Diagnostics Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 COMPANION DIAGNOSTICS MARKET COMPETITIVE LANDSCAPE
3.1 Global Companion Diagnostics Sales by Manufacturers (2019-2024)
3.2 Global Companion Diagnostics Revenue Market Share by Manufacturers (2019-2024)
3.3 Companion Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Companion Diagnostics Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Companion Diagnostics Sales Sites, Area Served, Product Type
3.6 Companion Diagnostics Market Competitive Situation and Trends
3.6.1 Companion Diagnostics Market Concentration Rate
3.6.2 Global 5 and 10 Largest Companion Diagnostics Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 COMPANION DIAGNOSTICS INDUSTRY CHAIN ANALYSIS
4.1 Companion Diagnostics Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF COMPANION DIAGNOSTICS MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 COMPANION DIAGNOSTICS MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Companion Diagnostics Sales Market Share by Type (2019-2024)
6.3 Global Companion Diagnostics Market Size Market Share by Type (2019-2024)
6.4 Global Companion Diagnostics Price by Type (2019-2024)
7 COMPANION DIAGNOSTICS MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Companion Diagnostics Market Sales by Application (2019-2024)
7.3 Global Companion Diagnostics Market Size (M USD) by Application (2019-2024)
7.4 Global Companion Diagnostics Sales Growth Rate by Application (2019-2024)
8 COMPANION DIAGNOSTICS MARKET SEGMENTATION BY REGION
8.1 Global Companion Diagnostics Sales by Region
8.1.1 Global Companion Diagnostics Sales by Region
8.1.2 Global Companion Diagnostics Sales Market Share by Region
8.2 North America
8.2.1 North America Companion Diagnostics Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Companion Diagnostics Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Companion Diagnostics Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Companion Diagnostics Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Companion Diagnostics Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Roche Holdings
9.1.1 Roche Holdings Companion Diagnostics Basic Information
9.1.2 Roche Holdings Companion Diagnostics Product Overview
9.1.3 Roche Holdings Companion Diagnostics Product Market Performance
9.1.4 Roche Holdings Business Overview
9.1.5 Roche Holdings Companion Diagnostics SWOT Analysis
9.1.6 Roche Holdings Recent Developments
9.2 Abbott Laboratories
9.2.1 Abbott Laboratories Companion Diagnostics Basic Information
9.2.2 Abbott Laboratories Companion Diagnostics Product Overview
9.2.3 Abbott Laboratories Companion Diagnostics Product Market Performance
9.2.4 Abbott Laboratories Business Overview
9.2.5 Abbott Laboratories Companion Diagnostics SWOT Analysis
9.2.6 Abbott Laboratories Recent Developments
9.3 Thermo Fisher Scientific
9.3.1 Thermo Fisher Scientific Companion Diagnostics Basic Information
9.3.2 Thermo Fisher Scientific Companion Diagnostics Product Overview
9.3.3 Thermo Fisher Scientific Companion Diagnostics Product Market Performance
9.3.4 Thermo Fisher Scientific Companion Diagnostics SWOT Analysis
9.3.5 Thermo Fisher Scientific Business Overview
9.3.6 Thermo Fisher Scientific Recent Developments
9.4 Agilent Technologies
9.4.1 Agilent Technologies Companion Diagnostics Basic Information
9.4.2 Agilent Technologies Companion Diagnostics Product Overview
9.4.3 Agilent Technologies Companion Diagnostics Product Market Performance
9.4.4 Agilent Technologies Business Overview
9.4.5 Agilent Technologies Recent Developments
9.5 Life Technologies
9.5.1 Life Technologies Companion Diagnostics Basic Information
9.5.2 Life Technologies Companion Diagnostics Product Overview
9.5.3 Life Technologies Companion Diagnostics Product Market Performance
9.5.4 Life Technologies Business Overview
9.5.5 Life Technologies Recent Developments
9.6 GE Healthcare
9.6.1 GE Healthcare Companion Diagnostics Basic Information
9.6.2 GE Healthcare Companion Diagnostics Product Overview
9.6.3 GE Healthcare Companion Diagnostics Product Market Performance
9.6.4 GE Healthcare Business Overview
9.6.5 GE Healthcare Recent Developments
9.7 Agendia
9.7.1 Agendia Companion Diagnostics Basic Information
9.7.2 Agendia Companion Diagnostics Product Overview
9.7.3 Agendia Companion Diagnostics Product Market Performance
9.7.4 Agendia Business Overview
9.7.5 Agendia Recent Developments
9.8 Qiagen
9.8.1 Qiagen Companion Diagnostics Basic Information
9.8.2 Qiagen Companion Diagnostics Product Overview
9.8.3 Qiagen Companion Diagnostics Product Market Performance
9.8.4 Qiagen Business Overview
9.8.5 Qiagen Recent Developments
9.9 Genomic Health
9.9.1 Genomic Health Companion Diagnostics Basic Information
9.9.2 Genomic Health Companion Diagnostics Product Overview
9.9.3 Genomic Health Companion Diagnostics Product Market Performance
9.9.4 Genomic Health Business Overview
9.9.5 Genomic Health Recent Developments
9.10 Myriad Genetics
9.10.1 Myriad Genetics Companion Diagnostics Basic Information
9.10.2 Myriad Genetics Companion Diagnostics Product Overview
9.10.3 Myriad Genetics Companion Diagnostics Product Market Performance
9.10.4 Myriad Genetics Business Overview
9.10.5 Myriad Genetics Recent Developments
9.11 Advanced Cell Diagnostics
9.11.1 Advanced Cell Diagnostics Companion Diagnostics Basic Information
9.11.2 Advanced Cell Diagnostics Companion Diagnostics Product Overview
9.11.3 Advanced Cell Diagnostics Companion Diagnostics Product Market Performance
9.11.4 Advanced Cell Diagnostics Business Overview
9.11.5 Advanced Cell Diagnostics Recent Developments
9.12 Danaher
9.12.1 Danaher Companion Diagnostics Basic Information
9.12.2 Danaher Companion Diagnostics Product Overview
9.12.3 Danaher Companion Diagnostics Product Market Performance
9.12.4 Danaher Business Overview
9.12.5 Danaher Recent Developments
9.13 Applied Proteomics
9.13.1 Applied Proteomics Companion Diagnostics Basic Information
9.13.2 Applied Proteomics Companion Diagnostics Product Overview
9.13.3 Applied Proteomics Companion Diagnostics Product Market Performance
9.13.4 Applied Proteomics Business Overview
9.13.5 Applied Proteomics Recent Developments
10 COMPANION DIAGNOSTICS MARKET FORECAST BY REGION
10.1 Global Companion Diagnostics Market Size Forecast
10.2 Global Companion Diagnostics Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Companion Diagnostics Market Size Forecast by Country
10.2.3 Asia Pacific Companion Diagnostics Market Size Forecast by Region
10.2.4 South America Companion Diagnostics Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Companion Diagnostics by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Companion Diagnostics Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Companion Diagnostics by Type (2025-2030)
11.1.2 Global Companion Diagnostics Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Companion Diagnostics by Type (2025-2030)
11.2 Global Companion Diagnostics Market Forecast by Application (2025-2030)
11.2.1 Global Companion Diagnostics Sales (K Units) Forecast by Application
11.2.2 Global Companion Diagnostics Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Companion Diagnostics
1.2 Key Market Segments
1.2.1 Companion Diagnostics Segment by Type
1.2.2 Companion Diagnostics Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 COMPANION DIAGNOSTICS MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Companion Diagnostics Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Companion Diagnostics Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 COMPANION DIAGNOSTICS MARKET COMPETITIVE LANDSCAPE
3.1 Global Companion Diagnostics Sales by Manufacturers (2019-2024)
3.2 Global Companion Diagnostics Revenue Market Share by Manufacturers (2019-2024)
3.3 Companion Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Companion Diagnostics Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Companion Diagnostics Sales Sites, Area Served, Product Type
3.6 Companion Diagnostics Market Competitive Situation and Trends
3.6.1 Companion Diagnostics Market Concentration Rate
3.6.2 Global 5 and 10 Largest Companion Diagnostics Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 COMPANION DIAGNOSTICS INDUSTRY CHAIN ANALYSIS
4.1 Companion Diagnostics Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF COMPANION DIAGNOSTICS MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 COMPANION DIAGNOSTICS MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Companion Diagnostics Sales Market Share by Type (2019-2024)
6.3 Global Companion Diagnostics Market Size Market Share by Type (2019-2024)
6.4 Global Companion Diagnostics Price by Type (2019-2024)
7 COMPANION DIAGNOSTICS MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Companion Diagnostics Market Sales by Application (2019-2024)
7.3 Global Companion Diagnostics Market Size (M USD) by Application (2019-2024)
7.4 Global Companion Diagnostics Sales Growth Rate by Application (2019-2024)
8 COMPANION DIAGNOSTICS MARKET SEGMENTATION BY REGION
8.1 Global Companion Diagnostics Sales by Region
8.1.1 Global Companion Diagnostics Sales by Region
8.1.2 Global Companion Diagnostics Sales Market Share by Region
8.2 North America
8.2.1 North America Companion Diagnostics Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Companion Diagnostics Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Companion Diagnostics Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Companion Diagnostics Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Companion Diagnostics Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Roche Holdings
9.1.1 Roche Holdings Companion Diagnostics Basic Information
9.1.2 Roche Holdings Companion Diagnostics Product Overview
9.1.3 Roche Holdings Companion Diagnostics Product Market Performance
9.1.4 Roche Holdings Business Overview
9.1.5 Roche Holdings Companion Diagnostics SWOT Analysis
9.1.6 Roche Holdings Recent Developments
9.2 Abbott Laboratories
9.2.1 Abbott Laboratories Companion Diagnostics Basic Information
9.2.2 Abbott Laboratories Companion Diagnostics Product Overview
9.2.3 Abbott Laboratories Companion Diagnostics Product Market Performance
9.2.4 Abbott Laboratories Business Overview
9.2.5 Abbott Laboratories Companion Diagnostics SWOT Analysis
9.2.6 Abbott Laboratories Recent Developments
9.3 Thermo Fisher Scientific
9.3.1 Thermo Fisher Scientific Companion Diagnostics Basic Information
9.3.2 Thermo Fisher Scientific Companion Diagnostics Product Overview
9.3.3 Thermo Fisher Scientific Companion Diagnostics Product Market Performance
9.3.4 Thermo Fisher Scientific Companion Diagnostics SWOT Analysis
9.3.5 Thermo Fisher Scientific Business Overview
9.3.6 Thermo Fisher Scientific Recent Developments
9.4 Agilent Technologies
9.4.1 Agilent Technologies Companion Diagnostics Basic Information
9.4.2 Agilent Technologies Companion Diagnostics Product Overview
9.4.3 Agilent Technologies Companion Diagnostics Product Market Performance
9.4.4 Agilent Technologies Business Overview
9.4.5 Agilent Technologies Recent Developments
9.5 Life Technologies
9.5.1 Life Technologies Companion Diagnostics Basic Information
9.5.2 Life Technologies Companion Diagnostics Product Overview
9.5.3 Life Technologies Companion Diagnostics Product Market Performance
9.5.4 Life Technologies Business Overview
9.5.5 Life Technologies Recent Developments
9.6 GE Healthcare
9.6.1 GE Healthcare Companion Diagnostics Basic Information
9.6.2 GE Healthcare Companion Diagnostics Product Overview
9.6.3 GE Healthcare Companion Diagnostics Product Market Performance
9.6.4 GE Healthcare Business Overview
9.6.5 GE Healthcare Recent Developments
9.7 Agendia
9.7.1 Agendia Companion Diagnostics Basic Information
9.7.2 Agendia Companion Diagnostics Product Overview
9.7.3 Agendia Companion Diagnostics Product Market Performance
9.7.4 Agendia Business Overview
9.7.5 Agendia Recent Developments
9.8 Qiagen
9.8.1 Qiagen Companion Diagnostics Basic Information
9.8.2 Qiagen Companion Diagnostics Product Overview
9.8.3 Qiagen Companion Diagnostics Product Market Performance
9.8.4 Qiagen Business Overview
9.8.5 Qiagen Recent Developments
9.9 Genomic Health
9.9.1 Genomic Health Companion Diagnostics Basic Information
9.9.2 Genomic Health Companion Diagnostics Product Overview
9.9.3 Genomic Health Companion Diagnostics Product Market Performance
9.9.4 Genomic Health Business Overview
9.9.5 Genomic Health Recent Developments
9.10 Myriad Genetics
9.10.1 Myriad Genetics Companion Diagnostics Basic Information
9.10.2 Myriad Genetics Companion Diagnostics Product Overview
9.10.3 Myriad Genetics Companion Diagnostics Product Market Performance
9.10.4 Myriad Genetics Business Overview
9.10.5 Myriad Genetics Recent Developments
9.11 Advanced Cell Diagnostics
9.11.1 Advanced Cell Diagnostics Companion Diagnostics Basic Information
9.11.2 Advanced Cell Diagnostics Companion Diagnostics Product Overview
9.11.3 Advanced Cell Diagnostics Companion Diagnostics Product Market Performance
9.11.4 Advanced Cell Diagnostics Business Overview
9.11.5 Advanced Cell Diagnostics Recent Developments
9.12 Danaher
9.12.1 Danaher Companion Diagnostics Basic Information
9.12.2 Danaher Companion Diagnostics Product Overview
9.12.3 Danaher Companion Diagnostics Product Market Performance
9.12.4 Danaher Business Overview
9.12.5 Danaher Recent Developments
9.13 Applied Proteomics
9.13.1 Applied Proteomics Companion Diagnostics Basic Information
9.13.2 Applied Proteomics Companion Diagnostics Product Overview
9.13.3 Applied Proteomics Companion Diagnostics Product Market Performance
9.13.4 Applied Proteomics Business Overview
9.13.5 Applied Proteomics Recent Developments
10 COMPANION DIAGNOSTICS MARKET FORECAST BY REGION
10.1 Global Companion Diagnostics Market Size Forecast
10.2 Global Companion Diagnostics Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Companion Diagnostics Market Size Forecast by Country
10.2.3 Asia Pacific Companion Diagnostics Market Size Forecast by Region
10.2.4 South America Companion Diagnostics Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Companion Diagnostics by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Companion Diagnostics Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Companion Diagnostics by Type (2025-2030)
11.1.2 Global Companion Diagnostics Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Companion Diagnostics by Type (2025-2030)
11.2 Global Companion Diagnostics Market Forecast by Application (2025-2030)
11.2.1 Global Companion Diagnostics Sales (K Units) Forecast by Application
11.2.2 Global Companion Diagnostics Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Companion Diagnostics Market Size Comparison by Region (M USD)
Table 5. Global Companion Diagnostics Sales (K Units) by Manufacturers (2019-2024)
Table 6. Global Companion Diagnostics Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Companion Diagnostics Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Companion Diagnostics Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Companion Diagnostics as of 2022)
Table 10. Global Market Companion Diagnostics Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Companion Diagnostics Sales Sites and Area Served
Table 12. Manufacturers Companion Diagnostics Product Type
Table 13. Global Companion Diagnostics Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Companion Diagnostics
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Companion Diagnostics Market Challenges
Table 22. Global Companion Diagnostics Sales by Type (K Units)
Table 23. Global Companion Diagnostics Market Size by Type (M USD)
Table 24. Global Companion Diagnostics Sales (K Units) by Type (2019-2024)
Table 25. Global Companion Diagnostics Sales Market Share by Type (2019-2024)
Table 26. Global Companion Diagnostics Market Size (M USD) by Type (2019-2024)
Table 27. Global Companion Diagnostics Market Size Share by Type (2019-2024)
Table 28. Global Companion Diagnostics Price (USD/Unit) by Type (2019-2024)
Table 29. Global Companion Diagnostics Sales (K Units) by Application
Table 30. Global Companion Diagnostics Market Size by Application
Table 31. Global Companion Diagnostics Sales by Application (2019-2024) & (K Units)
Table 32. Global Companion Diagnostics Sales Market Share by Application (2019-2024)
Table 33. Global Companion Diagnostics Sales by Application (2019-2024) & (M USD)
Table 34. Global Companion Diagnostics Market Share by Application (2019-2024)
Table 35. Global Companion Diagnostics Sales Growth Rate by Application (2019-2024)
Table 36. Global Companion Diagnostics Sales by Region (2019-2024) & (K Units)
Table 37. Global Companion Diagnostics Sales Market Share by Region (2019-2024)
Table 38. North America Companion Diagnostics Sales by Country (2019-2024) & (K Units)
Table 39. Europe Companion Diagnostics Sales by Country (2019-2024) & (K Units)
Table 40. Asia Pacific Companion Diagnostics Sales by Region (2019-2024) & (K Units)
Table 41. South America Companion Diagnostics Sales by Country (2019-2024) & (K Units)
Table 42. Middle East and Africa Companion Diagnostics Sales by Region (2019-2024) & (K Units)
Table 43. Roche Holdings Companion Diagnostics Basic Information
Table 44. Roche Holdings Companion Diagnostics Product Overview
Table 45. Roche Holdings Companion Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 46. Roche Holdings Business Overview
Table 47. Roche Holdings Companion Diagnostics SWOT Analysis
Table 48. Roche Holdings Recent Developments
Table 49. Abbott Laboratories Companion Diagnostics Basic Information
Table 50. Abbott Laboratories Companion Diagnostics Product Overview
Table 51. Abbott Laboratories Companion Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 52. Abbott Laboratories Business Overview
Table 53. Abbott Laboratories Companion Diagnostics SWOT Analysis
Table 54. Abbott Laboratories Recent Developments
Table 55. Thermo Fisher Scientific Companion Diagnostics Basic Information
Table 56. Thermo Fisher Scientific Companion Diagnostics Product Overview
Table 57. Thermo Fisher Scientific Companion Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 58. Thermo Fisher Scientific Companion Diagnostics SWOT Analysis
Table 59. Thermo Fisher Scientific Business Overview
Table 60. Thermo Fisher Scientific Recent Developments
Table 61. Agilent Technologies Companion Diagnostics Basic Information
Table 62. Agilent Technologies Companion Diagnostics Product Overview
Table 63. Agilent Technologies Companion Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 64. Agilent Technologies Business Overview
Table 65. Agilent Technologies Recent Developments
Table 66. Life Technologies Companion Diagnostics Basic Information
Table 67. Life Technologies Companion Diagnostics Product Overview
Table 68. Life Technologies Companion Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 69. Life Technologies Business Overview
Table 70. Life Technologies Recent Developments
Table 71. GE Healthcare Companion Diagnostics Basic Information
Table 72. GE Healthcare Companion Diagnostics Product Overview
Table 73. GE Healthcare Companion Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 74. GE Healthcare Business Overview
Table 75. GE Healthcare Recent Developments
Table 76. Agendia Companion Diagnostics Basic Information
Table 77. Agendia Companion Diagnostics Product Overview
Table 78. Agendia Companion Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 79. Agendia Business Overview
Table 80. Agendia Recent Developments
Table 81. Qiagen Companion Diagnostics Basic Information
Table 82. Qiagen Companion Diagnostics Product Overview
Table 83. Qiagen Companion Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 84. Qiagen Business Overview
Table 85. Qiagen Recent Developments
Table 86. Genomic Health Companion Diagnostics Basic Information
Table 87. Genomic Health Companion Diagnostics Product Overview
Table 88. Genomic Health Companion Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 89. Genomic Health Business Overview
Table 90. Genomic Health Recent Developments
Table 91. Myriad Genetics Companion Diagnostics Basic Information
Table 92. Myriad Genetics Companion Diagnostics Product Overview
Table 93. Myriad Genetics Companion Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 94. Myriad Genetics Business Overview
Table 95. Myriad Genetics Recent Developments
Table 96. Advanced Cell Diagnostics Companion Diagnostics Basic Information
Table 97. Advanced Cell Diagnostics Companion Diagnostics Product Overview
Table 98. Advanced Cell Diagnostics Companion Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 99. Advanced Cell Diagnostics Business Overview
Table 100. Advanced Cell Diagnostics Recent Developments
Table 101. Danaher Companion Diagnostics Basic Information
Table 102. Danaher Companion Diagnostics Product Overview
Table 103. Danaher Companion Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 104. Danaher Business Overview
Table 105. Danaher Recent Developments
Table 106. Applied Proteomics Companion Diagnostics Basic Information
Table 107. Applied Proteomics Companion Diagnostics Product Overview
Table 108. Applied Proteomics Companion Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 109. Applied Proteomics Business Overview
Table 110. Applied Proteomics Recent Developments
Table 111. Global Companion Diagnostics Sales Forecast by Region (2025-2030) & (K Units)
Table 112. Global Companion Diagnostics Market Size Forecast by Region (2025-2030) & (M USD)
Table 113. North America Companion Diagnostics Sales Forecast by Country (2025-2030) & (K Units)
Table 114. North America Companion Diagnostics Market Size Forecast by Country (2025-2030) & (M USD)
Table 115. Europe Companion Diagnostics Sales Forecast by Country (2025-2030) & (K Units)
Table 116. Europe Companion Diagnostics Market Size Forecast by Country (2025-2030) & (M USD)
Table 117. Asia Pacific Companion Diagnostics Sales Forecast by Region (2025-2030) & (K Units)
Table 118. Asia Pacific Companion Diagnostics Market Size Forecast by Region (2025-2030) & (M USD)
Table 119. South America Companion Diagnostics Sales Forecast by Country (2025-2030) & (K Units)
Table 120. South America Companion Diagnostics Market Size Forecast by Country (2025-2030) & (M USD)
Table 121. Middle East and Africa Companion Diagnostics Consumption Forecast by Country (2025-2030) & (Units)
Table 122. Middle East and Africa Companion Diagnostics Market Size Forecast by Country (2025-2030) & (M USD)
Table 123. Global Companion Diagnostics Sales Forecast by Type (2025-2030) & (K Units)
Table 124. Global Companion Diagnostics Market Size Forecast by Type (2025-2030) & (M USD)
Table 125. Global Companion Diagnostics Price Forecast by Type (2025-2030) & (USD/Unit)
Table 126. Global Companion Diagnostics Sales (K Units) Forecast by Application (2025-2030)
Table 127. Global Companion Diagnostics Market Size Forecast by Application (2025-2030) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Companion Diagnostics Market Size Comparison by Region (M USD)
Table 5. Global Companion Diagnostics Sales (K Units) by Manufacturers (2019-2024)
Table 6. Global Companion Diagnostics Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Companion Diagnostics Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Companion Diagnostics Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Companion Diagnostics as of 2022)
Table 10. Global Market Companion Diagnostics Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Companion Diagnostics Sales Sites and Area Served
Table 12. Manufacturers Companion Diagnostics Product Type
Table 13. Global Companion Diagnostics Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Companion Diagnostics
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Companion Diagnostics Market Challenges
Table 22. Global Companion Diagnostics Sales by Type (K Units)
Table 23. Global Companion Diagnostics Market Size by Type (M USD)
Table 24. Global Companion Diagnostics Sales (K Units) by Type (2019-2024)
Table 25. Global Companion Diagnostics Sales Market Share by Type (2019-2024)
Table 26. Global Companion Diagnostics Market Size (M USD) by Type (2019-2024)
Table 27. Global Companion Diagnostics Market Size Share by Type (2019-2024)
Table 28. Global Companion Diagnostics Price (USD/Unit) by Type (2019-2024)
Table 29. Global Companion Diagnostics Sales (K Units) by Application
Table 30. Global Companion Diagnostics Market Size by Application
Table 31. Global Companion Diagnostics Sales by Application (2019-2024) & (K Units)
Table 32. Global Companion Diagnostics Sales Market Share by Application (2019-2024)
Table 33. Global Companion Diagnostics Sales by Application (2019-2024) & (M USD)
Table 34. Global Companion Diagnostics Market Share by Application (2019-2024)
Table 35. Global Companion Diagnostics Sales Growth Rate by Application (2019-2024)
Table 36. Global Companion Diagnostics Sales by Region (2019-2024) & (K Units)
Table 37. Global Companion Diagnostics Sales Market Share by Region (2019-2024)
Table 38. North America Companion Diagnostics Sales by Country (2019-2024) & (K Units)
Table 39. Europe Companion Diagnostics Sales by Country (2019-2024) & (K Units)
Table 40. Asia Pacific Companion Diagnostics Sales by Region (2019-2024) & (K Units)
Table 41. South America Companion Diagnostics Sales by Country (2019-2024) & (K Units)
Table 42. Middle East and Africa Companion Diagnostics Sales by Region (2019-2024) & (K Units)
Table 43. Roche Holdings Companion Diagnostics Basic Information
Table 44. Roche Holdings Companion Diagnostics Product Overview
Table 45. Roche Holdings Companion Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 46. Roche Holdings Business Overview
Table 47. Roche Holdings Companion Diagnostics SWOT Analysis
Table 48. Roche Holdings Recent Developments
Table 49. Abbott Laboratories Companion Diagnostics Basic Information
Table 50. Abbott Laboratories Companion Diagnostics Product Overview
Table 51. Abbott Laboratories Companion Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 52. Abbott Laboratories Business Overview
Table 53. Abbott Laboratories Companion Diagnostics SWOT Analysis
Table 54. Abbott Laboratories Recent Developments
Table 55. Thermo Fisher Scientific Companion Diagnostics Basic Information
Table 56. Thermo Fisher Scientific Companion Diagnostics Product Overview
Table 57. Thermo Fisher Scientific Companion Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 58. Thermo Fisher Scientific Companion Diagnostics SWOT Analysis
Table 59. Thermo Fisher Scientific Business Overview
Table 60. Thermo Fisher Scientific Recent Developments
Table 61. Agilent Technologies Companion Diagnostics Basic Information
Table 62. Agilent Technologies Companion Diagnostics Product Overview
Table 63. Agilent Technologies Companion Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 64. Agilent Technologies Business Overview
Table 65. Agilent Technologies Recent Developments
Table 66. Life Technologies Companion Diagnostics Basic Information
Table 67. Life Technologies Companion Diagnostics Product Overview
Table 68. Life Technologies Companion Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 69. Life Technologies Business Overview
Table 70. Life Technologies Recent Developments
Table 71. GE Healthcare Companion Diagnostics Basic Information
Table 72. GE Healthcare Companion Diagnostics Product Overview
Table 73. GE Healthcare Companion Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 74. GE Healthcare Business Overview
Table 75. GE Healthcare Recent Developments
Table 76. Agendia Companion Diagnostics Basic Information
Table 77. Agendia Companion Diagnostics Product Overview
Table 78. Agendia Companion Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 79. Agendia Business Overview
Table 80. Agendia Recent Developments
Table 81. Qiagen Companion Diagnostics Basic Information
Table 82. Qiagen Companion Diagnostics Product Overview
Table 83. Qiagen Companion Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 84. Qiagen Business Overview
Table 85. Qiagen Recent Developments
Table 86. Genomic Health Companion Diagnostics Basic Information
Table 87. Genomic Health Companion Diagnostics Product Overview
Table 88. Genomic Health Companion Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 89. Genomic Health Business Overview
Table 90. Genomic Health Recent Developments
Table 91. Myriad Genetics Companion Diagnostics Basic Information
Table 92. Myriad Genetics Companion Diagnostics Product Overview
Table 93. Myriad Genetics Companion Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 94. Myriad Genetics Business Overview
Table 95. Myriad Genetics Recent Developments
Table 96. Advanced Cell Diagnostics Companion Diagnostics Basic Information
Table 97. Advanced Cell Diagnostics Companion Diagnostics Product Overview
Table 98. Advanced Cell Diagnostics Companion Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 99. Advanced Cell Diagnostics Business Overview
Table 100. Advanced Cell Diagnostics Recent Developments
Table 101. Danaher Companion Diagnostics Basic Information
Table 102. Danaher Companion Diagnostics Product Overview
Table 103. Danaher Companion Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 104. Danaher Business Overview
Table 105. Danaher Recent Developments
Table 106. Applied Proteomics Companion Diagnostics Basic Information
Table 107. Applied Proteomics Companion Diagnostics Product Overview
Table 108. Applied Proteomics Companion Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 109. Applied Proteomics Business Overview
Table 110. Applied Proteomics Recent Developments
Table 111. Global Companion Diagnostics Sales Forecast by Region (2025-2030) & (K Units)
Table 112. Global Companion Diagnostics Market Size Forecast by Region (2025-2030) & (M USD)
Table 113. North America Companion Diagnostics Sales Forecast by Country (2025-2030) & (K Units)
Table 114. North America Companion Diagnostics Market Size Forecast by Country (2025-2030) & (M USD)
Table 115. Europe Companion Diagnostics Sales Forecast by Country (2025-2030) & (K Units)
Table 116. Europe Companion Diagnostics Market Size Forecast by Country (2025-2030) & (M USD)
Table 117. Asia Pacific Companion Diagnostics Sales Forecast by Region (2025-2030) & (K Units)
Table 118. Asia Pacific Companion Diagnostics Market Size Forecast by Region (2025-2030) & (M USD)
Table 119. South America Companion Diagnostics Sales Forecast by Country (2025-2030) & (K Units)
Table 120. South America Companion Diagnostics Market Size Forecast by Country (2025-2030) & (M USD)
Table 121. Middle East and Africa Companion Diagnostics Consumption Forecast by Country (2025-2030) & (Units)
Table 122. Middle East and Africa Companion Diagnostics Market Size Forecast by Country (2025-2030) & (M USD)
Table 123. Global Companion Diagnostics Sales Forecast by Type (2025-2030) & (K Units)
Table 124. Global Companion Diagnostics Market Size Forecast by Type (2025-2030) & (M USD)
Table 125. Global Companion Diagnostics Price Forecast by Type (2025-2030) & (USD/Unit)
Table 126. Global Companion Diagnostics Sales (K Units) Forecast by Application (2025-2030)
Table 127. Global Companion Diagnostics Market Size Forecast by Application (2025-2030) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Companion Diagnostics
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Companion Diagnostics Market Size (M USD), 2019-2030
Figure 5. Global Companion Diagnostics Market Size (M USD) (2019-2030)
Figure 6. Global Companion Diagnostics Sales (K Units) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Companion Diagnostics Market Size by Country (M USD)
Figure 11. Companion Diagnostics Sales Share by Manufacturers in 2023
Figure 12. Global Companion Diagnostics Revenue Share by Manufacturers in 2023
Figure 13. Companion Diagnostics Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Companion Diagnostics Average Price (USD/Unit) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Companion Diagnostics Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Companion Diagnostics Market Share by Type
Figure 18. Sales Market Share of Companion Diagnostics by Type (2019-2024)
Figure 19. Sales Market Share of Companion Diagnostics by Type in 2023
Figure 20. Market Size Share of Companion Diagnostics by Type (2019-2024)
Figure 21. Market Size Market Share of Companion Diagnostics by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Companion Diagnostics Market Share by Application
Figure 24. Global Companion Diagnostics Sales Market Share by Application (2019-2024)
Figure 25. Global Companion Diagnostics Sales Market Share by Application in 2023
Figure 26. Global Companion Diagnostics Market Share by Application (2019-2024)
Figure 27. Global Companion Diagnostics Market Share by Application in 2023
Figure 28. Global Companion Diagnostics Sales Growth Rate by Application (2019-2024)
Figure 29. Global Companion Diagnostics Sales Market Share by Region (2019-2024)
Figure 30. North America Companion Diagnostics Sales and Growth Rate (2019-2024) & (K Units)
Figure 31. North America Companion Diagnostics Sales Market Share by Country in 2023
Figure 32. U.S. Companion Diagnostics Sales and Growth Rate (2019-2024) & (K Units)
Figure 33. Canada Companion Diagnostics Sales (K Units) and Growth Rate (2019-2024)
Figure 34. Mexico Companion Diagnostics Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Companion Diagnostics Sales and Growth Rate (2019-2024) & (K Units)
Figure 36. Europe Companion Diagnostics Sales Market Share by Country in 2023
Figure 37. Germany Companion Diagnostics Sales and Growth Rate (2019-2024) & (K Units)
Figure 38. France Companion Diagnostics Sales and Growth Rate (2019-2024) & (K Units)
Figure 39. U.K. Companion Diagnostics Sales and Growth Rate (2019-2024) & (K Units)
Figure 40. Italy Companion Diagnostics Sales and Growth Rate (2019-2024) & (K Units)
Figure 41. Russia Companion Diagnostics Sales and Growth Rate (2019-2024) & (K Units)
Figure 42. Asia Pacific Companion Diagnostics Sales and Growth Rate (K Units)
Figure 43. Asia Pacific Companion Diagnostics Sales Market Share by Region in 2023
Figure 44. China Companion Diagnostics Sales and Growth Rate (2019-2024) & (K Units)
Figure 45. Japan Companion Diagnostics Sales and Growth Rate (2019-2024) & (K Units)
Figure 46. South Korea Companion Diagnostics Sales and Growth Rate (2019-2024) & (K Units)
Figure 47. India Companion Diagnostics Sales and Growth Rate (2019-2024) & (K Units)
Figure 48. Southeast Asia Companion Diagnostics Sales and Growth Rate (2019-2024) & (K Units)
Figure 49. South America Companion Diagnostics Sales and Growth Rate (K Units)
Figure 50. South America Companion Diagnostics Sales Market Share by Country in 2023
Figure 51. Brazil Companion Diagnostics Sales and Growth Rate (2019-2024) & (K Units)
Figure 52. Argentina Companion Diagnostics Sales and Growth Rate (2019-2024) & (K Units)
Figure 53. Columbia Companion Diagnostics Sales and Growth Rate (2019-2024) & (K Units)
Figure 54. Middle East and Africa Companion Diagnostics Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa Companion Diagnostics Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Companion Diagnostics Sales and Growth Rate (2019-2024) & (K Units)
Figure 57. UAE Companion Diagnostics Sales and Growth Rate (2019-2024) & (K Units)
Figure 58. Egypt Companion Diagnostics Sales and Growth Rate (2019-2024) & (K Units)
Figure 59. Nigeria Companion Diagnostics Sales and Growth Rate (2019-2024) & (K Units)
Figure 60. South Africa Companion Diagnostics Sales and Growth Rate (2019-2024) & (K Units)
Figure 61. Global Companion Diagnostics Sales Forecast by Volume (2019-2030) & (K Units)
Figure 62. Global Companion Diagnostics Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Companion Diagnostics Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Companion Diagnostics Market Share Forecast by Type (2025-2030)
Figure 65. Global Companion Diagnostics Sales Forecast by Application (2025-2030)
Figure 66. Global Companion Diagnostics Market Share Forecast by Application (2025-2030)
Figure 1. Product Picture of Companion Diagnostics
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Companion Diagnostics Market Size (M USD), 2019-2030
Figure 5. Global Companion Diagnostics Market Size (M USD) (2019-2030)
Figure 6. Global Companion Diagnostics Sales (K Units) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Companion Diagnostics Market Size by Country (M USD)
Figure 11. Companion Diagnostics Sales Share by Manufacturers in 2023
Figure 12. Global Companion Diagnostics Revenue Share by Manufacturers in 2023
Figure 13. Companion Diagnostics Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Companion Diagnostics Average Price (USD/Unit) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Companion Diagnostics Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Companion Diagnostics Market Share by Type
Figure 18. Sales Market Share of Companion Diagnostics by Type (2019-2024)
Figure 19. Sales Market Share of Companion Diagnostics by Type in 2023
Figure 20. Market Size Share of Companion Diagnostics by Type (2019-2024)
Figure 21. Market Size Market Share of Companion Diagnostics by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Companion Diagnostics Market Share by Application
Figure 24. Global Companion Diagnostics Sales Market Share by Application (2019-2024)
Figure 25. Global Companion Diagnostics Sales Market Share by Application in 2023
Figure 26. Global Companion Diagnostics Market Share by Application (2019-2024)
Figure 27. Global Companion Diagnostics Market Share by Application in 2023
Figure 28. Global Companion Diagnostics Sales Growth Rate by Application (2019-2024)
Figure 29. Global Companion Diagnostics Sales Market Share by Region (2019-2024)
Figure 30. North America Companion Diagnostics Sales and Growth Rate (2019-2024) & (K Units)
Figure 31. North America Companion Diagnostics Sales Market Share by Country in 2023
Figure 32. U.S. Companion Diagnostics Sales and Growth Rate (2019-2024) & (K Units)
Figure 33. Canada Companion Diagnostics Sales (K Units) and Growth Rate (2019-2024)
Figure 34. Mexico Companion Diagnostics Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Companion Diagnostics Sales and Growth Rate (2019-2024) & (K Units)
Figure 36. Europe Companion Diagnostics Sales Market Share by Country in 2023
Figure 37. Germany Companion Diagnostics Sales and Growth Rate (2019-2024) & (K Units)
Figure 38. France Companion Diagnostics Sales and Growth Rate (2019-2024) & (K Units)
Figure 39. U.K. Companion Diagnostics Sales and Growth Rate (2019-2024) & (K Units)
Figure 40. Italy Companion Diagnostics Sales and Growth Rate (2019-2024) & (K Units)
Figure 41. Russia Companion Diagnostics Sales and Growth Rate (2019-2024) & (K Units)
Figure 42. Asia Pacific Companion Diagnostics Sales and Growth Rate (K Units)
Figure 43. Asia Pacific Companion Diagnostics Sales Market Share by Region in 2023
Figure 44. China Companion Diagnostics Sales and Growth Rate (2019-2024) & (K Units)
Figure 45. Japan Companion Diagnostics Sales and Growth Rate (2019-2024) & (K Units)
Figure 46. South Korea Companion Diagnostics Sales and Growth Rate (2019-2024) & (K Units)
Figure 47. India Companion Diagnostics Sales and Growth Rate (2019-2024) & (K Units)
Figure 48. Southeast Asia Companion Diagnostics Sales and Growth Rate (2019-2024) & (K Units)
Figure 49. South America Companion Diagnostics Sales and Growth Rate (K Units)
Figure 50. South America Companion Diagnostics Sales Market Share by Country in 2023
Figure 51. Brazil Companion Diagnostics Sales and Growth Rate (2019-2024) & (K Units)
Figure 52. Argentina Companion Diagnostics Sales and Growth Rate (2019-2024) & (K Units)
Figure 53. Columbia Companion Diagnostics Sales and Growth Rate (2019-2024) & (K Units)
Figure 54. Middle East and Africa Companion Diagnostics Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa Companion Diagnostics Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Companion Diagnostics Sales and Growth Rate (2019-2024) & (K Units)
Figure 57. UAE Companion Diagnostics Sales and Growth Rate (2019-2024) & (K Units)
Figure 58. Egypt Companion Diagnostics Sales and Growth Rate (2019-2024) & (K Units)
Figure 59. Nigeria Companion Diagnostics Sales and Growth Rate (2019-2024) & (K Units)
Figure 60. South Africa Companion Diagnostics Sales and Growth Rate (2019-2024) & (K Units)
Figure 61. Global Companion Diagnostics Sales Forecast by Volume (2019-2030) & (K Units)
Figure 62. Global Companion Diagnostics Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Companion Diagnostics Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Companion Diagnostics Market Share Forecast by Type (2025-2030)
Figure 65. Global Companion Diagnostics Sales Forecast by Application (2025-2030)
Figure 66. Global Companion Diagnostics Market Share Forecast by Application (2025-2030)
